75N95023F00001↗
Booz Allen Hamilton Inc received this contract from National Institutes of Health Nida, National Institutes of Health: $12.15M obligated so far for health r&d services; health care services; basic research. Its period of performance ended 2024-09-16.
Key facts · data as of Oct 25, 2026
- Recipient
- Booz Allen Hamilton Inc
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nida (75N950)
- Obligated to date
- $12.15M
- Potential value
- $12.15M
- Ends
- 2024-09-16
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N95023F00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N95023F00001_7529_75N95021D00023_7529
Booz Allen Hamilton Inc: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nida: what it buys
NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2023 - SEPTEMBER 16, 2024. N01DA-21-5588 TASK ORDER 75N95023F00001 (TO3).
What it is
- Product or service
- Health R&D Services; Health Care Services; Basic Research (PSC AN11)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- National Institutes of Health Nida (75N950)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75N95021D00023
- Solicitation
- 75N95023F00001
- Where the work is
- Fairfax, VA · district VA-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
3 subawards totaling $10.34M (85.1% of what was obligated), as Booz Allen Hamilton Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Infinity Biologix LLC | $8.29M | 1 | NJ | 2024-01-23 | 2024-01-23 |
| United States Drug Testing Laboratories, Inc. | $2.05M | 2 | IL | 2023-11-08 | 2024-09-23 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2024-01-23 | Infinity Biologix LLC | $8.29M | SAMPLE BIOSTORAGE AND LAB SERVICES |
| 2023-11-08 | United States Drug Testing Laboratories, Inc. | $1.05M | TOXICOLOGICAL ANALYSIS OF BIOLOGICAL TISSUES AND FLUIDS |
| 2024-09-23 | United States Drug Testing Laboratories, Inc. | $1.00M | TOXICOLOGICAL ANALYSIS OF BIOLOGICAL TISSUES AND FLUIDS |
Every action
2 actions since 2023-09-07. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-14 | P00001 | Funding only | -$2.9K | FY26 UDO INITIATIVE. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2023 - SEPTEMBER 16, 2024. N01DA-21-5588 TASK ORDER 75N95023F00001 (TO3). |
| 2023-09-07 | 0 | $12.15M | NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2023 - SEPTEMBER 16, 2024. N01DA-21-5588 TASK ORDER 75N95023F00001 (TO3). |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗